These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4409501)

  • 1. [Evaluation of a therapeutics committee's work].
    Dolby J; Ekblom B; Elfvik P; Gunne LM; Jansson S; Kalling M; Nordlander NB; Skagerberg H; Anggård E
    Lakartidningen; 1974 Sep; 71(37):3355-6. PubMed ID: 4409501
    [No Abstract]   [Full Text] [Related]  

  • 2. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satisfying the P and T committee's need for more evidence.
    Cross M
    Manag Care; 2006 Oct; 15(10):22-4, 26-8, 31. PubMed ID: 17111693
    [No Abstract]   [Full Text] [Related]  

  • 4. The P&T Committee's role in managing drugs for rare diseases.
    Tadlock C
    Manag Care Interface; 2007 Jun; 20(6):10, 13. PubMed ID: 17708076
    [No Abstract]   [Full Text] [Related]  

  • 5. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The drug committee at an ordinary hospital--is it capable of anything?].
    Bergfors PG; Ogren JE
    Lakartidningen; 1974 Jul; 71(27):2658-9. PubMed ID: 4839608
    [No Abstract]   [Full Text] [Related]  

  • 9. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent antibiotic use evaluation in a community hospital.
    Merryfield DW; Wooten JM; Gupta MR
    Hosp Formul; 1991 Oct; 26(10):820-2. PubMed ID: 10114500
    [No Abstract]   [Full Text] [Related]  

  • 14. [Swedish drug information of international interest].
    Osterberg S
    Lakartidningen; 1975 Jun; 72(26):2743. PubMed ID: 1142909
    [No Abstract]   [Full Text] [Related]  

  • 15. Some research opportunities in hospital pharmacy.
    Wertheimer AI
    Am J Hosp Pharm; 1981 Oct; 38(10):1534-6. PubMed ID: 7294056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health economic evaluation of recommended drug treatment].
    Jendteg S; Persson U; Anell A
    Lakartidningen; 2002 Jul; 99(30-31):3130-1. PubMed ID: 12198934
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of a hospital drug committee's recommendations on the use of analgesics as evaluated by drug-use data.
    Hartvig P; Isacson D; Bingefors K
    J Clin Hosp Pharm; 1982 Sep; 7(3):161-7. PubMed ID: 7174830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted formulary drugs: an exploratory study.
    Rucker TD
    Hosp Pharm; 1982 May; 17(5):246-53. PubMed ID: 10255245
    [No Abstract]   [Full Text] [Related]  

  • 19. [The chairman of the drug committees: limit the reporting requirement between pharmacy and the prescribing physician concerning generic drug exchange].
    Back S; Widäng K
    Lakartidningen; 2002 Dec; 99(49):5005. PubMed ID: 12522991
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug committees in Sweden].
    Barkman R
    Tidsskr Nor Laegeforen; 1970 Jan; 90(1):1-3. PubMed ID: 5448711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.